Literature DB >> 8199600

D2 dopamine receptor gene and obesity.

E P Noble1, R E Noble, T Ritchie, K Syndulko, M C Bohlman, L A Noble, Y Zhang, R S Sparkes, D K Grandy.   

Abstract

The prevalence of Taql A D2 dopamine receptor (DRD2) alleles was determined in 73 obese women and men. In this sample with a mean body mass index of 35.1, the A1 (minor) allele of the DRD2 gene was present in 45.2% of these nonalcohol, nondrug abusing subjects. The DRD2 A1 allele was not associated with a number of cardiovascular risk factors examined, including blood lipids (cholesterol, high-density lipoprotein [HDL]- and low-density lipoprotein [LDL]-cholesterol, and triglycerides). However, phenotypic factors characterized by the presence of parental history and postpuberty onset of obesity as well as carbohydrate preference were associated with obese subjects carrying the A1 allele. The cumulative number of these three factors was positively and significantly (p < .0002) related to A1 allelic prevalence. The data showing an association of the minor allele of the DRD2 gene with phenotypic characteristics suggest that this gene, located on q22-q23 region of chromosome 11, confers susceptibility to a subtype of this disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199600     DOI: 10.1002/1098-108x(199404)15:3<205::aid-eat2260150303>3.0.co;2-p

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  50 in total

1.  Energy homeostasis and body weight in obesity: new physiopathological and therapeutic considerations.

Authors:  G Magnati; A Dei Cas
Journal:  Eat Weight Disord       Date:  2000-09       Impact factor: 4.652

2.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

3.  An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.

Authors:  Meltem Sevgi; Lionel Rigoux; Anne B Kühn; Jan Mauer; Leonhard Schilbach; Martin E Hess; Theo O J Gruendler; Markus Ullsperger; Klaas Enno Stephan; Jens C Brüning; Marc Tittgemeyer
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 4.  Food reinforcement and eating: a multilevel analysis.

Authors:  Leonard H Epstein; John J Leddy; Jennifer L Temple; Myles S Faith
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

5.  Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults.

Authors:  Erin Green; Aaron Jacobson; Lori Haase; Claire Murphy
Journal:  Brain Res       Date:  2011-03-24       Impact factor: 3.252

6.  Neural correlates of taste and pleasantness evaluation in the metabolic syndrome.

Authors:  Erin Green; Aaron Jacobson; Lori Haase; Claire Murphy
Journal:  Brain Res       Date:  2015-04-02       Impact factor: 3.252

7.  The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women.

Authors:  Jameason D Cameron; Marie-Ève Riou; Frédérique Tesson; Gary S Goldfield; Rémi Rabasa-Lhoret; Martin Brochu; Éric Doucet
Journal:  Appetite       Date:  2012-09-29       Impact factor: 3.868

8.  Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele.

Authors:  S M Berman; E P Noble
Journal:  Behav Genet       Date:  1995-01       Impact factor: 2.805

9.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

10.  Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Marek Niedoszytko; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2009-09-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.